Example: quiz answers
PACKAGE LEAFLET: INFORMATION FOR THE USER COPD …
6. Contents of the pack and other information 1.hat Spiriva Respimat is and what W it is used for Spiriva Respimat helps people who have chronic obstructive pulmonary disease (COPD) or asthma to breathe more easily. COPD is a long-term lung disease that causes shortness of breath and coughing. The term COPD is associated with the conditions
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
PFIZER Package leaflet: Information for the patient …
www.medicines.org.ukPage 1 of 20 PFIZER Package leaflet: Information for the patient Depo-Provera® 150 mg/ml Sterile Suspension for Injection Medroxyprogesterone acetate Please read all of this leaflet carefully before you start using this medicine because it
PACKAGE LEAFLET: INFORMATION FOR THE USER
www.medicines.org.uk1.3.1 Package Leaflet 1 Package leaflet: Information for the patient Laxido Orange, powder for oral solution. Read all of this leaflet carefully before you start taking this medicine because it contains
Package leaflet: Information for the user - Medicines
www.medicines.org.ukPage 1 of 8 v019_0 Due to regulatory changes, the content of the following Patient Information Leaflet may vary from the one found in your medicine pack.
Patient Information Leaflet - Medicines
www.medicines.org.ukPage 2 of 10 Patient Information Leaflet Salazopyrin® EN-tabs 500 mg enteric-coated tablets sulfasalazine In this leaflet: 1. What Salazopyrin EN …
Package leaflet: Information for the user Clexane …
www.medicines.org.uk1 Package leaflet: Information for the user. Clexane® Syringes 2,000 IU (20 mg)/0.2 ml solution for injection in pre-filled syringes . Clexane® Syringes 4,000 IU (40 mg)/0.4 ml solution for injection in pre-filled syringes
PACKAGE LEAFLET: INFORMATION FOR THE USER
www.medicines.org.uk1.3.1. Package Leaflet 1 PACKAGE LEAFLET: INFORMATION FOR THE USER CALCEOS 500mg/400IU CHEWABLE TABLETS …
Package leaflet: Information for the user …
www.medicines.org.ukRead all of this leaflet carefully before you start taking this medicine because it contains important information for you. • Keep this leaflet.
PACKAGE LEAFLET: INFORMATION FOR THE USER …
www.medicines.org.ukPACKAGE LEAFLET: INFORMATION FOR THE USER Bisoprolol 2.5 mg Film-coated Tablet Bisoprolol 5 mg Film-coated Tablet Bisoprolol 10 mg Film-coated Tablet
SAYANA PRESS 104 mg/0.65 ml suspension for …
www.medicines.org.ukPage 1 of 15 Package leaflet: Information for the user SAYANA PRESS® 104 mg/0.65 ml suspension for injection medroxyprogesterone acetate Single-dose container ...
small pharma code may appear on the front / back …
www.medicines.org.ukKeep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the blister and carton after EXP.
Related documents
HIGHLIGHTS OF PRESCRIBING INFORMATION …
docs.boehringer-ingelheim.comSee 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling. ... Sinusitis 11 9 3 2 Pharyngitis 9 7 7 3 Rhinitis 6 5 3 2 Epistaxis 4 2 1 1 Skin and Appendage Disorders Rash 4 2 2 2 Urinary System Urinary Tract Infection 7 5 4 2 Arthritis, coughing, and influenza-like symptoms occurred at a rate of ≥3% in the SPIRIVA HANDIHALER ...
HIGHLIGHTS OF PRESCRIBING INFORMATION
gskpro.comrespiratory tract infection, sinusitis/acute sinusitis, urinary tract infection, rhinitis, influenza, headache, and back pain . (6.2) To report SUSPECTED ADVERSE REACTIONS, contact GlaxoSmithKline at 1 -888-825-5249 or FDA at 1 -800-FDA-1088 or ... 17 PATIENT COUNSELING INFORMATION
HIGHLIGHTS OF PRESCRIBING INFORMATION • for FLOVENT …
gskpro.com17 PATIENT COUNSELING INFORMATION * Sections or subsections omitted from the full prescribing information are not listed. _____ FULL PRESCRIBING INFORMATION . 1 INDICATIONS AND USAGE . FLOVENT HFA is indicated for the maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients aged 4 years and older.
SYMBICORT Prescribing Information
den8dhaj6zs0e.cloudfront.netSee 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling Revised: 07/2019. US-31454. FULL PRESCRIBING INFORMATION: CONTENTS * 1 INDICATIONS AND USAGE. 1.1 Treatment of Asthma 1.2 Maintenance Treatment of Chronic Obstructive Pulmonary Disease. 2 DOSAGE AND ADMINISTRATION. 2.1 Administration …
BREZTRI Full Prescribing Information
den8dhaj6zs0e.cloudfront.netpatient’s inhaled, short-acting beta. 2-agonist becomes less effective or the patient needs more inhalations of short-acting beta. 2-agonist than usual, these may be markers of deterioration of disease. In this setting, re-evaluate the patient and the COPD treatment regimen at once. The daily dosage of BREZTRI AEROSPHERE